These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32993519)

  • 1. Performance of unanchored matching-adjusted indirect comparison (MAIC) for the evidence synthesis of single-arm trials with time-to-event outcomes.
    Jiang Y; Ni W
    BMC Med Res Methodol; 2020 Sep; 20(1):241. PubMed ID: 32993519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing unanchored simulated treatment comparisons: A novel implementation and simulation study.
    Ren S; Ren S; Welton NJ; Strong M
    Res Synth Methods; 2024 Jul; 15(4):657-670. PubMed ID: 38590103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-stage matching-adjusted indirect comparison.
    Remiro-Azócar A
    BMC Med Res Methodol; 2022 Aug; 22(1):217. PubMed ID: 35941551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Model Misspecification in Unanchored Matching-Adjusted Indirect Comparison: Results of a Simulation Study.
    Hatswell AJ; Freemantle N; Baio G
    Value Health; 2020 Jun; 23(6):751-759. PubMed ID: 32540233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments.
    Kapetanakis V; Prawitz T; Schlichting M; Ishak KJ; Phatak H; Yu T; Bharmal M
    Value Health; 2021 Aug; 24(8):1137-1144. PubMed ID: 34372979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review and shiny application on the matching-adjusted indirect comparison.
    Jiang Z; Cappelleri JC; Gamalo M; Chen Y; Thomas N; Chu H
    Res Synth Methods; 2024 Jul; 15(4):671-686. PubMed ID: 38380799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Adjusted and Unadjusted Indirect Comparison Methods in Benefit Assessment. A Simulation Study for Time-to-event Endpoints.
    Kühnast S; Schiffner-Rohe J; Rahnenführer J; Leverkus F
    Methods Inf Med; 2017 May; 56(3):261-267. PubMed ID: 28361159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unanchored Population-Adjusted Indirect Comparison Methods for Time-to-Event Outcomes Using Inverse Odds Weighting, Regression Adjustment, and Doubly Robust Methods With Either Individual Patient or Aggregate Data.
    Park JE; Campbell H; Towle K; Yuan Y; Jansen JP; Phillippo D; Cope S
    Value Health; 2024 Mar; 27(3):278-286. PubMed ID: 38135212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Matching-Adjusted Indirect Comparisons in Practice: A Case Study of Patients with Attention-Deficit/Hyperactivity Disorder.
    Shafrin J; Shrestha A; Chandra A; Erder MH; Sikirica V
    Health Econ; 2017 Nov; 26(11):1459-1466. PubMed ID: 27620206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for population adjustment with limited access to individual patient data: A review and simulation study.
    Remiro-Azócar A; Heath A; Baio G
    Res Synth Methods; 2021 Nov; 12(6):750-775. PubMed ID: 34196111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel.
    Cartron G; Fox CP; Liu FF; Kostic A; Hasskarl J; Li D; Bonner A; Zhang Y; Maloney DG; Kuruvilla J
    Exp Hematol Oncol; 2022 Mar; 11(1):17. PubMed ID: 35337365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Methods for Estimating Therapy Effects by Indirect Comparisons: A Simulation Study.
    Weber D; Jensen K; Kieser M
    Med Decis Making; 2020 Jul; 40(5):644-654. PubMed ID: 32659160
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment-Schedule Matching in Unanchored Indirect Treatment Comparisons of Progression-Free Survival in Cancer Studies.
    Kapetanakis V; Prawitz T; Schlichting M; Ishak KJ; Phatak H; Kearney M; Stevens JW; Benedict A; Bharmal M
    Pharmacoeconomics; 2019 Dec; 37(12):1537-1551. PubMed ID: 31555968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalence of entropy balancing and the method of moments for matching-adjusted indirect comparison.
    Phillippo DM; Dias S; Ades AE; Welton NJ
    Res Synth Methods; 2020 Jul; 11(4):568-572. PubMed ID: 32395870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the impact of a matching-adjusted indirect comparison in a Bayesian network meta-analysis.
    Leahy J; Walsh C
    Res Synth Methods; 2019 Dec; 10(4):546-568. PubMed ID: 31368653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative weighting schemes when performing matching-adjusted indirect comparisons.
    Jackson D; Rhodes K; Ouwens M
    Res Synth Methods; 2021 May; 12(3):333-346. PubMed ID: 33131206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the double-robustness and semiparametric efficiency of matching-adjusted indirect comparisons.
    Cheng D; Tchetgen ET; Signorovitch J
    Res Synth Methods; 2023 May; 14(3):438-442. PubMed ID: 36537355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect comparison of the antiviral efficacy of peginterferon alpha 2a plus ribavirin used with or without simeprevir in genotype 4 hepatitis C virus infection, where common comparator study arms are lacking: a special application of the matching adjusted indirect comparison methodology.
    Van Sanden S; Pisini M; Duchesne I; Mehnert A; Belsey J
    Curr Med Res Opin; 2016; 32(1):147-54. PubMed ID: 26455472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of several matching adjusted indirect comparisons (MAICs) with an application in psoriasis.
    Saure D; Schacht A; Kadziola Z; Brnabic AJM
    Pharm Stat; 2020 Sep; 19(5):532-540. PubMed ID: 32115845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geometric approaches to assessing the numerical feasibility for conducting matching-adjusted indirect comparisons.
    Glimm E; Yau L
    Pharm Stat; 2022 Sep; 21(5):974-987. PubMed ID: 35343622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.